• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Articles published by Humacyte, Inc

    Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Announces Two Presentations at the VEITHsymposium® of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Third Quarter 2023 Financial Results and Business Update
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 9, 2023
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Publishes Preclinical Results Showing Human Acellular Vessel™ (HAV™) Patency as Modified Blalock–Taussig–Thomas Shunt in Juvenile Primate Model
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Present at the Cantor Global Healthcare Conference
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Announces Positive Top Line Results from Phase 2/3 Trial of Human Acellular Vessel™ (HAV™) in Treatment of Patients with Vascular Trauma
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Announce Top Line Data from Phase 2/3 V005 Trial in Vascular Trauma Evaluating its Human Acellular Vessel™ (HAV™) Tuesday, September 12, 2023 at 8:00 AM ET
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Results From Mayo Clinic Clinical Study of Humacyte’s Human Acellular Vessel™ (HAV™) in Treatment of Patients with Chronic Limb Ischemia Presented at Midwestern Vascular Conference
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Second Quarter 2023 Financial Results and Business Update
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Announces Fourth Quarter and Year End 2022 Financial Results and Business Update
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Present Fourth Quarter and Full Year Financial Results and Provide Corporate Update on March 24, 2023
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Present at Upcoming Investor Conferences in March
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Publication in the Journal of Vascular Surgery – Vascular Science Reports the Human Acellular Vessel™ (HAV™) Remains Durable at Six Years in Patients with Peripheral Artery Disease
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Hosting Key Opinion Leader Webinar on Vascular Trauma: Ukrainian Surgeons Discuss Use of Human Acellular Vessels™ (HAV™) in Wartime
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Human Acellular Vessel™ (HAV™) Ukraine Humanitarian Results to be Presented at Multiple Vascular Conferences in December 2022
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Present at the 34th Annual Piper Sandler Healthcare Conference
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Third Quarter 2022 Financial Results and Business Update
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte Presents Six-Month Human Acellular Vessel™ (HAV™) Coronary Artery Bypass Graft (CABG) Data at the American Heart Association Scientific Sessions 2022 Meeting
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Humacyte to Present Third Quarter Financial Results and Provide Corporate Update on November 10, 2022
    From Humacyte, Inc
    Via GlobeNewswire
    Tickers HUMA
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.